Abstract:This work developed a biohybrid bacterial system through genetic engineering and biomaterial hybridization in which CDH17 nanobodies are engineered onto the bacteria for tumor targeting and a photothermal material croconium (CR) dye is conjugated on bacteria for PTT induction. When combined with checkpoint blockade CD47 nanobody, the biohybrid bacteria successfully eradicated the tumors through STING activation, and considerably extended survival of the mice. Bacteria can be utilized for cancer therapy owing to their preferential colonization at tumor sites. However, unmodified non‐pathogenic bacteria carry potential risks due to their non‐specific targeting effects, and their anti‐tumor activity is limited when used as monotherapy. In this study, a biohybrid‐engineered bacterial system comprising non‐pathogenic MG1655 bacteria modified with CDH17 nanobodies on their surface and conjugated with photosensitizer croconium (CR) molecules is developed. The resultant biohybrid bacteria can efficiently home to CDH17‐positive tumors, including gastric, pancreatic, and colorectal cancers, and significantly suppress tumor growth upon irradiation. More importantly, biohybrid bacteria‐mediated photothermal therapy (PTT) induced abundant macrophage infiltration in a syngeneic murine colorectal model. Further, that the STING pathway is activated in tumor macrophages by the released bacterial nucleic acid after PTT is revealed, leading to the production of type I interferons. The addition of CD47 nanobody but not PD‐1 antibody to the PTT regimen can eradicate the tumors and extend survival. This results indicate that bacteria endowed with tumor‐specific selectivity and coupled with photothermal payloads can serve as an innovative strategy for low‐immunogenicity cancers. This strategy can potentially reprogram the tumor microenvironment by inducing macrophage infiltration and enhancing the efficacy of immunotherapy targeting macrophages.

Engineered Bacteria for Augmentedin Situtumor Vaccination

Engineered Microorganisms for Advancing Tumor Therapy

Engineered Bacteria: Strategies and Applications in Cancer Immunotherapy

Engineered Bacteriophage-Based in Situ Vaccine Remodels a Tumor Microenvironment and Elicits Potent Antitumor Immunity.

Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapy

Engineering Bacteria and Their Derivatives for Cancer Immunotherapy

Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy

Progress of engineered bacteria for tumor therapy

Engineering Nanoparticle-Coated Bacteria As Oral DNA Vaccines for Cancer Immunotherapy.

In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity

Engineered Living Bacteriophage-Enabled Self-Adjuvanting Hydrogel for Remodeling Tumor Microenvironment and Cancer Therapy

Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria

Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity

Ultrasound-controllable engineered bacteria for cancer immunotherapy

Nanomaterial combined engineered bacteria for intelligent tumor immunotherapy

Phytochemical Engineered Bacterial Outer Membrane Vesicles for Photodynamic Effects Promoted Immunotherapy.

Bacterium‐Mimicking Vector with Enhanced Adjuvanticity for Cancer Immunotherapy and Minimized Toxicity

Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity

Bacteria engineered with intracellular and extracellular nanomaterials for hierarchical modulation of antitumor immune responses

Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma

Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy